These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23996844)

  • 21. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis.
    Foglia B; Cannito S; Bocca C; Parola M; Novo E
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiogenesis and Fibrogenesis in Chronic Liver Diseases.
    Bocca C; Novo E; Miglietta A; Parola M
    Cell Mol Gastroenterol Hepatol; 2015 Sep; 1(5):477-488. PubMed ID: 28210697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver fibrosis: from the bench to clinical targets.
    Pinzani M; Rombouts K
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.
    Wigerup C; Påhlman S; Bexell D
    Pharmacol Ther; 2016 Aug; 164():152-69. PubMed ID: 27139518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
    Svegliati-Baroni G; De Minicis S; Marzioni M
    Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
    Iwaisako K; Brenner DA; Kisseleva T
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inducible factors for cancer-associated fibroblasts in liver cancer versus myofibroblasts in inflammatory liver disease.
    Okabe H; Hayashi H; Nakagawa S; Imai K; Nitta H; Arima K; Hashimoto D; Chikamoto A; Ishiko T; Beppu T; Baba H
    Histol Histopathol; 2016 Feb; 31(2):141-8. PubMed ID: 26398776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.
    Mallat A; Lotersztajn S
    Am J Physiol Cell Physiol; 2013 Oct; 305(8):C789-99. PubMed ID: 23903700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans.
    Novo E; Marra F; Zamara E; Valfrè di Bonzo L; Monitillo L; Cannito S; Petrai I; Mazzocca A; Bonacchi A; De Franco RS; Colombatto S; Autelli R; Pinzani M; Parola M
    Gut; 2006 Aug; 55(8):1174-82. PubMed ID: 16423888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UCHL1-dependent control of hypoxia-inducible factor transcriptional activity during liver fibrosis.
    Collins A; Scott R; Wilson CL; Abbate G; Ecclestone GB; Albanese AG; Biddles D; White S; French J; Moir J; Alrawashdeh W; Wilson C; Pandanaboyana S; Hammond JS; Thakkar R; Oakley F; Mann J; Mann DA; Kenneth NS
    Biosci Rep; 2024 Jun; 44(6):. PubMed ID: 38808772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology of Liver Fibrosis.
    Pinzani M
    Dig Dis; 2015; 33(4):492-7. PubMed ID: 26159264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retina-specific activation of a sustained hypoxia-like response leads to severe retinal degeneration and loss of vision.
    Lange C; Caprara C; Tanimoto N; Beck S; Huber G; Samardzija M; Seeliger M; Grimm C
    Neurobiol Dis; 2011 Jan; 41(1):119-30. PubMed ID: 20817091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrosis in the liver: acute protection and chronic disease.
    Lee Y; Friedman SL
    Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ever-expanding role of HIF in tumour and stromal biology.
    LaGory EL; Giaccia AJ
    Nat Cell Biol; 2016 Apr; 18(4):356-65. PubMed ID: 27027486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors.
    Arjamaa O; Nikinmaa M
    Exp Eye Res; 2006 Sep; 83(3):473-83. PubMed ID: 16750526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
    Gressner AM
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NcoA2-Dependent Inhibition of HIF-1α Activation Is Regulated via AhR.
    Tsai CH; Li CH; Liao PL; Cheng YW; Lin CH; Huang SH; Kang JJ
    Toxicol Sci; 2015 Dec; 148(2):517-30. PubMed ID: 26350169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?
    Pinzani M
    J Hepatol; 2011 Aug; 55(2):459-65. PubMed ID: 21320559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.
    Coch L; Mejias M; Berzigotti A; Garcia-Pras E; Gallego J; Bosch J; Mendez R; Fernandez M
    Hepatology; 2014 Aug; 60(2):633-47. PubMed ID: 24390792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of adaptive angiogenesis to tissue hypoxia.
    Fong GH
    Angiogenesis; 2008; 11(2):121-40. PubMed ID: 18327686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.